These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3155644)

  • 1. T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1.
    Schulof RS; Chorba TL; Cleary PA; Palaszynski SR; Alabaster O; Goldstein AL
    Cancer; 1985 Mar; 55(5):974-83. PubMed ID: 3155644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
    Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
    J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A.
    Kessler CM; Schulof RS; Alabaster O; Goldstein AL; Naylor PH; Phillips TM; Luban NL; Kelleher JF; Reaman GH
    Br J Haematol; 1984 Oct; 58(2):325-36. PubMed ID: 6236839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin alpha 1 enhances while thymosin beta 4 suppresses the human autologous and allogeneic mixed lymphocyte reaction.
    Baxevanis CN; Reclos GJ; Perez S; Kokkinopoulos D; Papamichail M
    Immunopharmacology; 1987 Apr; 13(2):133-41. PubMed ID: 2954929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer.
    Schulof RS; Lloyd MJ; Cleary PA; Palaszynski SR; Mai DA; Cox JW; Alabaster O; Goldstein AL
    J Biol Response Mod; 1985 Apr; 4(2):147-58. PubMed ID: 3998766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation changes in cord blood T lymphocytes induced by synthetic C-terminal peptides of thymosin alpha 1.
    Ho AD; Stehle B; Birr C; Heinzel W; Nebe TC
    Thymus; 1987; 9(2):77-84. PubMed ID: 3035761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitivity of isolated subsets of human lymphocytes (E+, OKT4+, OKT8+): protective role of monocytes and monokines.
    Manori I; Kushilevsky A; Segal S; Weinstein Y
    Clin Exp Immunol; 1984 Nov; 58(2):453-61. PubMed ID: 6238736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asbestos exposure correlates with alterations in circulating T cell subsets.
    Miller LG; Sparrow D; Ginns LC
    Clin Exp Immunol; 1983 Jan; 51(1):110-6. PubMed ID: 6600988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymosin in vitro on T cell levels during radiation therapy: correlations with radiation portal and initial T cell levels.
    Kenady DE; Chretien PB; Potvin C; Simon RM; Alexander JC; Goldstein AL
    Cancer; 1977 Feb; 39(2):642-52. PubMed ID: 402187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of human T lymphocyte functions by prothymosin alpha. I. Augmentation of mixed lymphocyte culture reactions and soluble protein-induced proliferative responses.
    Baxevanis CN; Reclos GJ; Panneerselvam C; Papamichail M
    Immunopharmacology; 1988; 15(2):73-84. PubMed ID: 2967267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
    Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
    J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma.
    Wolf GT; Peterson KA; Lovett EJ
    Head Neck Surg; 1985; 7(5):350-6. PubMed ID: 3879957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
    Murray JL; Reuben JM; Smith TL; Gehan EA; Koretz SM; Hersh EM
    J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thymosin on cellular immunity in old age.
    Cowan MJ; Fujiwara P; Wara DW; Ammann AJ
    Mech Ageing Dev; 1981 Jan; 15(1):29-39. PubMed ID: 6456383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.
    Fox RI; Fong S; Sabharwal N; Carstens SA; Kung PC; Vaughan JH
    J Immunol; 1982 Jan; 128(1):351-4. PubMed ID: 6976376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 and aging: decreased interleukin-2 production in healthy older people does not correlate with reduced helper cell numbers or antibody response to influenza vaccine and is not corrected in vitro by thymosin alpha 1.
    Ershler WB; Moore AL; Roessner K; Ranges GE
    Immunopharmacology; 1985 Aug; 10(1):11-7. PubMed ID: 2932408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating thymulin and thymosin-alpha 1 activity in pediatric acquired immune deficiency syndrome: in vivo and in vitro studies.
    Rubinstein A; Novick BE; Sicklick MJ; Bernstein LJ; Incefy GS; Naylor PH; Goldstein AL
    J Pediatr; 1986 Sep; 109(3):422-7. PubMed ID: 3018210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission.
    Liberati AM; Ballatori E; Fizzotti M; Schippa M; Cini L; Cinieri S; Proietti MG; Di Marzio R; Senatore M; Grignani F
    Cancer Immunol Immunother; 1988; 26(1):87-93. PubMed ID: 3125973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal differentiation of cord blood lymphocytes induced by thymosin fraction 5 and thymosin alpha 1.
    Ho AD; Stehle B; Dietz G; Hunstein W; Hoffbrand AV
    Scand J Immunol; 1985 Mar; 21(3):221-5. PubMed ID: 2986276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.